Abstract
The Angiotensin II for the Treatment of Vasodilatory Shock (ATHOS-3) trial demonstrated the vasopressor effects and catecholamine-sparing properties o......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
